Investment Management Corp of Ontario (IMCO)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Investment Management Corp of Ontario (IMCO)'s BMY Position: Q2 2026 in Review
Investment Management Corp of Ontario (IMCO) reduced its Bristol-Myers Squibb (BMY) stake by 31% in Q2 2026, selling an estimated $5.75M and leaving 219,828 shares worth $12.7M. The position accounts for 0.16% of the portfolio, ranked #138.
Investment Management Corp of Ontario (IMCO) first reported a position in BMY in Q4 2022 and has held it in 14 quarters since. The position peaked at $21.7M in Q3 2025. 2,511 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Investment Management Corp of Ontario (IMCO) held 219,828 shares of Bristol-Myers Squibb worth $12.7M as of Q2 2026.
- Investment Management Corp of Ontario (IMCO) sold 100,202 Bristol-Myers Squibb shares in Q2 2026, an estimated $5.75M.
- Bristol-Myers Squibb made up 0.16% of Investment Management Corp of Ontario (IMCO)'s portfolio in Q2 2026, its #138 holding.
- Investment Management Corp of Ontario (IMCO) first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 14 quarters since.
- Investment Management Corp of Ontario (IMCO)'s Bristol-Myers Squibb position peaked at $21.7M in Q3 2025.
- 2,511 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Investment Management Corp of Ontario (IMCO)'s 13F filing for Q2 2026, filed 14 Aug 2026.